Amneal Pharmaceuticals, Inc.·4

Mar 12, 4:49 PM ET

Stewart Robert A 4

4 · Amneal Pharmaceuticals, Inc. · Filed Mar 12, 2019

Insider Transaction Report

Form 4
Period: 2019-03-12
Stewart Robert A
DirectorPresident & CEO
Transactions
  • Purchase

    Class A Common Stock

    2019-03-12$11.92/sh+17,000$202,64017,000 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.89 per share to $11.94 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    wf-form4_155242375114309.xmlPrimary

    FORM 4